Skip to main content
. Author manuscript; available in PMC: 2022 Feb 2.
Published in final edited form as: AIDS. 2021 Feb 2;35(2):325–334. doi: 10.1097/QAD.0000000000002748

Figure 1.

Figure 1.

Propensity score-matched hazard ratios (statin-exposed versus unexposed) for cancer groups*, specific cancer types, and mortality

* Microbial cancers include: human papillomavirus (HPV)-related oral cavity and pharynx squamous cell carcinoma (SCC), anal SCC, hepatocellular carcinoma (HCC); cancers of the stomach, lung, cervix, vulva, vagina, and penis; Hodgkin lymphoma, non-Hodgkin lymphoma, and Kaposi sarcoma

† P-value for HIV*statin interaction in combined model with HIV and uninfected patients

‡ Results presented for PWH only because there were only 6 anal squamous cell carcinoma and 0 Kaposi sarcoma cases among uninfected.